Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results; Establishes Outlook For First Half Of 2021

Go back to Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results; Establishes Outlook For First Half Of 2021

Quest Diagnostics (DGX) Tops Q4 EPS by 24c

February 4, 2021 6:48 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $4.48, $0.24 better than the analyst estimate of $4.24. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.93... More